FDA News, Events and other resources  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

News for Food and Drug Administration (FDA)

News > FDA

Listings 171 - 180 of 441:

ZyDoc MTS Alerts Doctors with Patients Affected by Avandia and Actos Drug Warnings
On August 14, 2007, the FDA issued a "black-box" cardiac risk warning label warning for the entire class of anti-diabetic drugs, known as thiazolidine...
FDA Approves Updated Warfarin (Coumadin) Prescribing Information
The U.S. Food and Drug Administration announced today the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain t...
FDA Asks Manufacturers of Diabetes Drugs to Strengthen Warning on Heart Failure Risk
The U.S. Food and Drug Administration announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning...
FDA Grants Tentative Approval for 50th and 51st Anti-Retroviral Drugs Under President's AIDS Relief Plan
The U.S. Food and Drug Administration, part of the U.S. Department of Health and Human Services, today granted tentative approval for nevirapine table...
FDA Takes Action Against Iowa Dairy for Illegal Drug Residues Found in Cows
A Complaint and Consent Decree of Permanent Injunction were filed Wednesday, August 8 in the U.S. District Court for the Northern District of Iowa, We...
FDA Warns Consumers to Avoid Eating Raw Oysters
The U.S. Food and Drug Administration is warning consumers not to eat raw oysters harvested from an area of the southern tip of Hood Canal in Washingt...
High Blood Pressure Medicine Diovan Gets Six Months Additonal Marketing Exclusivity from FDA
Diovan (valsartan) has been granted pediatric exclusivity by the US Food and Drug Administration (FDA) based on studies conducted in children with hig...
FDA Approves of Pfizer's AIDS Drug Selzentry
AIDS Healthcare Foundation (AHF) welcomed news that the FDA has approved Pfizer Inc.'s new AIDS salvage therapy, Selzentry (maraviroc), a different cl...
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted priority review status to the...
Escape Velocity Systems Demonstrates Compliance with FDA 21 CFR Part 11 Requirements
The FDA specifically states that the "agency expects the magnitude of these benefits should significantly outweigh the costs of making these system."A...


Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next

  Search this category:




Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.